Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia.
Bartlett MJ, Flores AJ, Ye T, Smidt SI, Dollish HK, Stancati JA, Farrell DC, Parent KL, Doyle KP, Besselsen DG, Heien ML, Cowen SL, Steece-Collier K, Sherman SJ, Falk T.
Bartlett MJ, et al. Among authors: parent kl.
Exp Neurol. 2020 Nov;333:113413. doi: 10.1016/j.expneurol.2020.113413. Epub 2020 Jul 25.
Exp Neurol. 2020.
PMID: 32717354
Free PMC article.